Dysthyroid optic neuropathy: evaluation and management

被引:65
|
作者
Dolman, P. J. [1 ]
机构
[1] Univ British Columbia, Vancouver Gen Hosp, Dept Ophthalmol & Visual Sci, Vancouver, BC, Canada
关键词
Thyroid eye disease; Graves orbitopathy; Dysthyroid optic neuropathy; Compressive optic neuropathy; Stretch optic neuropathy; Orbital decompression; GRAVES ORBITOPATHY EUGOGO; QUALITY-OF-LIFE; ORBITAL RADIOTHERAPY; EUROPEAN GROUP; TED-QOL; OPHTHALMOPATHY; DISEASE; RISK; QUESTIONNAIRE; DECOMPRESSION;
D O I
10.1007/s40618-020-01361-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Dysthyroid optic neuropathy (DON) is a serious complication of Graves orbitopathy (GO) from optic nerve dysfunction that may result in permanent loss of vision. Purpose This paper reviews the current knowledge of DON, including its pathogenesis and epidemiology, clinical and radiologic features, and management choices and outcomes. Methods Literature review and author retrospective case series. Results Over 90% of DON cases are related to nerve compression by enlarged extraocular muscles (EOM) while the remainder are caused by stretching of the optic nerve without compression. DON's incidence is 5-8% of GO cases. Risk factors include advancing age, male gender, smoking and diabetes mellitus, and these cases should be referred promptly to an ophthalmologist or GO clinic to rule out DON and for ongoing care. Clinical features of DON may include reduction in central and colour vision (unexplained by other ocular disorders), afferent pupil defect and/or optic disc edema. Since most cases are associated with enlarged EOM, restricted motility and soft tissue venous congestion are common. Visual fields and optical coherence tomography (OCT) help confirm the diagnosis while CT or MRI Scans show apical optic nerve compression or proptosis with optic nerve stretch. Standard therapy includes iv/oral corticosteroids (CS) with partial response in most cases, but often relapse with tapering. Radiotherapy may delay or avoid surgery and may prevent the onset of DON when combined with CS in high-risk individuals. The benefits of newer biologic targeted therapy are not clear. Orbital decompression surgery often has positive outcomes, even in cases of severe vision loss or delayed surgery. The most common surgical complication is worsening strabismus, which may worsen visual function and quality of life. In rare cases, permanent vision loss from DON may occur despite full therapy. Conclusions Although DON may cause vision loss, most cases are reversible if recognized and managed in a timely manner.
引用
收藏
页码:421 / 429
页数:9
相关论文
共 50 条
  • [1] Dysthyroid optic neuropathy: evaluation and management
    P. J. Dolman
    Journal of Endocrinological Investigation, 2021, 44 : 421 - 429
  • [2] MANAGEMENT OF DYSTHYROID OPTIC NEUROPATHY
    KLINGELE, TG
    HART, WM
    BURDE, RM
    OPHTHALMOLOGICA, 1977, 174 (06) : 327 - 335
  • [3] DYSTHYROID OPTIC NEUROPATHY - CLINICAL PROFILE AND RATIONALE FOR MANAGEMENT
    TROBE, JD
    GLASER, JS
    LAFLAMME, P
    ARCHIVES OF OPHTHALMOLOGY, 1978, 96 (07) : 1199 - 1209
  • [4] Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy
    Zou, Mengsha
    Wu, Dide
    Zhu, Hongzhang
    Huang, Xiahua
    Zhao, Xiaojuan
    Zhao, Jing
    Fu, Wenhao
    Li, Ruocheng
    Li, Bin
    Wan, Pengxia
    Hong, Shubin
    Li, Yanbing
    Xiao, Haipeng
    Yang, Zhiyun
    EUROPEAN RADIOLOGY, 2022, 32 (03) : 1931 - 1938
  • [5] Surgical management of dysthyroid optic neuropathy: A systematic review
    Meunier, A.
    Haissaguerre, M.
    Majoufre, C.
    Schlund, M.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2024, 125 (01)
  • [6] Evaluation of visual evoked potentials in dysthyroid optic neuropathy
    Kuebler, Aylin Garip
    Halfter, Kathrin
    Reznicek, Lukas
    Klingenstein, Annemarie
    Priglinger, Siegfried
    Rudolph, Gunther
    Hintschich, Christoph
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2023, 42 (05): : 475 - 480
  • [7] Subclinical dysthyroid optic neuropathy: tritan deficiency as an early sign of dysthyroid optic neuropathy
    Garip-Kuebler, Aylin
    Halfter, Kathrin
    Reznicek, Lukas
    Klingenstein, Annemarie
    Priglinger, Siegfried
    Hintschich, Christoph R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2021, 105 (07) : 1019 - 1023
  • [8] Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy
    Mengsha Zou
    Dide Wu
    Hongzhang Zhu
    Xiahua Huang
    Xiaojuan Zhao
    Jing Zhao
    Wenhao Fu
    Ruocheng Li
    Bin Li
    Pengxia Wan
    Shubin Hong
    Yanbing Li
    Haipeng Xiao
    Zhiyun Yang
    European Radiology, 2022, 32 : 1931 - 1938
  • [9] Commentary: Dysthyroid optic neuropathy
    Rath, Suryasnata
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (12) : 4426 - 4428
  • [10] Imaging of dysthyroid optic neuropathy
    Rana, Khizar
    Garg, Devanshu
    Patel, Sandy
    Selva, Dinesh
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2024, 34 (05) : 1346 - 1354